Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $12.00, but opened at $11.71. Pieris Pharmaceuticals shares last traded at $11.30, with a volume of 14,761 shares traded. Wall Street Analysts Forecast Growth Separately, StockNews.com started coverage on Pieris […]
Investment analysts at StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Get Free Report) in a note issued to investors on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of PIRS stock opened at $0.15 on Friday. Pieris Pharmaceuticals has a one year low […]
Shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report) saw unusually-strong trading volume on Tuesday . Approximately 31,577 shares traded hands during trading, an increase of 316% from the previous session’s volume of 7,598 shares.The stock last traded at $11.65 and had previously closed at $11.69. Analyst Ratings Changes Separately, StockNews.com initiated coverage on […]
BOSTON, MA - Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company s common stock, par value $0.001, which will be.
Equities research analysts at StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Get Free Report) in a report released on Sunday. The firm set a “hold” rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance Shares of PIRS stock opened at $0.15 on Friday. The business’s fifty day moving average price is […]